|
May 1
|
Amphastar Pharmaceuticals (AMPH) Reports Next Week: Wall Street Expects Earnings Growth
|
|
Apr 30
|
Amphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 8, 2024
|
|
Apr 30
|
Why Amphastar (AMPH) Could Beat Earnings Estimates Again
|
|
Apr 12
|
Amphastar Pharmaceuticals (NASDAQ:AMPH) shareholders YoY returns are lagging the company's 66% three-year earnings growth
|
|
Apr 4
|
Amphastar Pharmaceuticals (AMPH) Stock Moves -1%: What You Should Know
|
|
Apr 1
|
Amphastar Pharmaceuticals to Present at the 23rd Annual Needham Virtual Healthcare Conference
|
|
Mar 27
|
Is Amphastar (AMPH) a Buy as Wall Street Analysts Look Optimistic?
|
|
Mar 11
|
Brokers Suggest Investing in Amphastar (AMPH): Read This Before Placing a Bet
|
|
Mar 9
|
Amphastar Pharmaceuticals Inc CFO, EVP & Treasurer William Peters Sells 18,136 Shares
|
|
Mar 7
|
Amphastar Pharmaceuticals Inc Director Michael Zasloff Sells 12,500 Shares
|
|
Mar 6
|
Amphastar Pharmaceuticals to Present at the Barclays 26th Annual Global Healthcare Conference
|
|
Feb 9
|
Amphastar Pharmaceuticals (AMPH) Laps the Stock Market: Here's Why
|
|
Feb 5
|
Amphastar Pharmaceuticals (AMPH) Dips More Than Broader Market: What You Should Know
|
|
Feb 1
|
Institutional investors in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) lost 3.4% last week but have reaped the benefits of longer-term growth
|
|
Jan 30
|
Amphastar Pharmaceuticals (AMPH) Falls More Steeply Than Broader Market: What Investors Need to Know
|
|
Jan 26
|
5 Top Growth Stocks to Buy as Recession Fears Subside
|
|
Jan 26
|
Zacks Industry Outlook Highlights Amphastar, Teva and Dr. Reddy's
|
|
Jan 17
|
Amphastar Pharmaceuticals (AMPH) Gains As Market Dips: What You Should Know
|
|
Jan 11
|
Amphastar Pharmaceuticals (AMPH) Registers a Bigger Fall Than the Market: Important Facts to Note
|
|
Jan 5
|
Amphastar Pharmaceuticals (AMPH) Stock Drops Despite Market Gains: Important Facts to Note
|